[
  {
    "ts": null,
    "headline": "Stock Market Today: Dow, S&P Waffle As Netflix, GE Aerospace Earnings Loom (Live Coverage)",
    "summary": "The Dow Jones Industrial Average and other major stock indexes wavered in afternoon trading Friday as Wall Street looked ahead to a three-day weekend. Among the winners was obesity drug stock Novo Nordisk, which surged on the stock market today.",
    "url": "https://finnhub.io/api/news?id=939e912448ae6964ff6d0a3228446d4c8a92cdc33b8a135becefd413ddf10de5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768591341,
      "headline": "Stock Market Today: Dow, S&P Waffle As Netflix, GE Aerospace Earnings Loom (Live Coverage)",
      "id": 138155239,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The Dow Jones Industrial Average and other major stock indexes wavered in afternoon trading Friday as Wall Street looked ahead to a three-day weekend. Among the winners was obesity drug stock Novo Nordisk, which surged on the stock market today.",
      "url": "https://finnhub.io/api/news?id=939e912448ae6964ff6d0a3228446d4c8a92cdc33b8a135becefd413ddf10de5"
    }
  },
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Softer Friday Afternoon",
    "summary": "Health care stocks declined Friday afternoon with the NYSE Health Care Index easing 0.2% and the Sta",
    "url": "https://finnhub.io/api/news?id=7ab3fd2960ef82cbfe59c953d1fb7f40db2246040ea6eb8d76cc34401da92a07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768589248,
      "headline": "Sector Update: Health Care Stocks Softer Friday Afternoon",
      "id": 138155392,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Health care stocks declined Friday afternoon with the NYSE Health Care Index easing 0.2% and the Sta",
      "url": "https://finnhub.io/api/news?id=7ab3fd2960ef82cbfe59c953d1fb7f40db2246040ea6eb8d76cc34401da92a07"
    }
  },
  {
    "ts": null,
    "headline": "Shattuck Labs: \"Hold\" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot",
    "summary": "Shattuck Labs (STTK) pivots from oncology to focus on SL-325 for inflammatory bowel disorders, following underwhelming oncology data. Read the latest analysis on the stock here.",
    "url": "https://finnhub.io/api/news?id=4c322d9a5b4914dc25b184b5a581a4a92ac130c6e651956468effbaa886e995b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768570278,
      "headline": "Shattuck Labs: \"Hold\" On Oncology Exit And Competitive TL1A/DR3 Pathway Pivot",
      "id": 138154560,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2242672740/image_2242672740.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Shattuck Labs (STTK) pivots from oncology to focus on SL-325 for inflammatory bowel disorders, following underwhelming oncology data. Read the latest analysis on the stock here.",
      "url": "https://finnhub.io/api/news?id=4c322d9a5b4914dc25b184b5a581a4a92ac130c6e651956468effbaa886e995b"
    }
  },
  {
    "ts": null,
    "headline": "Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board",
    "summary": "TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman of the Company’s Board of Directors, effective January 15, 2026. Dr. Vink, M.D., M.B.A., has been an advisor to the pharmaceutical industry since 2015 and has served as a non-executive board member or chair of several public and private companies in North America and Europe. He has overseen or supported sev",
    "url": "https://finnhub.io/api/news?id=40c28d48c44e40af0adc390f03db57294387a981188ba78e28a6225b868a0194",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768569300,
      "headline": "Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board",
      "id": 138151756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman of the Company’s Board of Directors, effective January 15, 2026. Dr. Vink, M.D., M.B.A., has been an advisor to the pharmaceutical industry since 2015 and has served as a non-executive board member or chair of several public and private companies in North America and Europe. He has overseen or supported sev",
      "url": "https://finnhub.io/api/news?id=40c28d48c44e40af0adc390f03db57294387a981188ba78e28a6225b868a0194"
    }
  },
  {
    "ts": null,
    "headline": "XPH: Healthcare Dashboard For January",
    "summary": "The State Street SPDR S&P Pharmaceuticals ETF provides equal-weight exposure and cuts single-stock risk. Click here to read my latest analysis of XPH.",
    "url": "https://finnhub.io/api/news?id=88a66b183c88d1dec9678cebfd94abf7fdd27ceb7d9b4ff3369fa886b09cba9c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768566072,
      "headline": "XPH: Healthcare Dashboard For January",
      "id": 138153468,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1434365911/image_1434365911.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The State Street SPDR S&P Pharmaceuticals ETF provides equal-weight exposure and cuts single-stock risk. Click here to read my latest analysis of XPH.",
      "url": "https://finnhub.io/api/news?id=88a66b183c88d1dec9678cebfd94abf7fdd27ceb7d9b4ff3369fa886b09cba9c"
    }
  },
  {
    "ts": null,
    "headline": "2 Unpopular Stocks That Should Get More Attention and 1 We Brush Off",
    "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
    "url": "https://finnhub.io/api/news?id=00523b2bb4eef76afd9fe583c795610114ec113af2547ed06aa55f52cefafe42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1768538170,
      "headline": "2 Unpopular Stocks That Should Get More Attention and 1 We Brush Off",
      "id": 138152549,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.",
      "url": "https://finnhub.io/api/news?id=00523b2bb4eef76afd9fe583c795610114ec113af2547ed06aa55f52cefafe42"
    }
  }
]